Nitrogen Degradation Pathways in Actinomycetes: Key Components of Primary Metabolism Ensuring Survival in the Environment
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Nitrogen is an essential element required for bacterial homeostasis. It serves as a building block for the biosynthesis of macromolecules and provides precursors for secondary metabolites. Actinomycetes have developed the ability to use various nitrogen sources to ensure their survival in ecological niches with fluctuating nutrient availability. A complex nitrogen metabolism of Actinobacteria allows the utilization of various compounds as N sources, including ammonium, nitrate, urea, amino acids, amino sugars, and amines. One such adaptation is the ability to acquire nitrogen from alternative amine sources like monoamines or polyamines putrescine, cadaverine, spermidine, and spermine, ensuring both nutrient availability (C and N sources) and resistance against high polyamine concentrations. Actinobacterial nitrogen degradation, including the catabolism of amines, is not only important under low nitrogen availability, but also required to survive under high concentrations of these compounds. The purpose of this review is to summarize the knowledge on nitrogen degradation and, more specifically, catabolism of amines in Actinobacterial survival and its role in nitrogen metabolism. Applying critical analysis of the recent available literature and sequencing data, this work aims to explore strategies of pathogenic and non-pathogenic Actinobacteria to survive in the presence of different nitrogen sources, and their impact on primary and secondary metabolism. The knowledge about nitrogen degradation pathways in Actinobacteria including mono- and polyamine catabolism collected in the scope of this review paper is brought in connection with possibilities to combat pathogens by using their capability to metabolize polyamines as an antibiotic drug target. This might offer new directions for target-based drug design to combat Actinobacterial infections.